With no new bladder cancer treatment approvals in 30 years, 2016 proved to be a breakthrough year in bladder cancer research. It kicked off this year’s rapid expansion of several immunotherapies now available to patients with metastatic bladder cancer, revolutionizing the treatment of this disease. “Before, we could offer chemotherapy, which
